Brief: Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea
14/05/2026 18:52
May 14 (Reuters) - Incannex Healthcare Inc IXHL.O: INCANNEX HEALTHCARE INC - COMMENCES DREAMZZ CLINICAL STUDY OF IHL-42X FOR OBSTRUCTIVE SLEEP APNEA Source text: ID:nGNX2tfPJn Further company coverage: IXHL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Incannex Healthcare
See all newsIncannex Healthcare Inc reports results for the quarter ended June 30 - Earnings Summary
Incannex Healthcare Inc expected to post a loss of 75 cents a share - Earnings Preview
Brief: Incannex Receives Additional A$5.1 Million Research And Development Tax Incentive Refund
Brief: Incannex Healthcare Commences DReAMzz Clinical Study Of IHL-42X For Obstructive Sleep Apnea
Brief: Incannex Reactivates Share Repurchase Program, Underscoring Confidence In Valuation And Strategic Position